CompletedPhase 3NCT00144599

Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chugai Pharmaceutical
Principal Investigator
Takahiro Kakehi
Chugai Pharmaceutical
Intervention
MRA(Tocilizumab)(drug)
Enrollment
56 enrolled
Eligibility
2-19 years · All sexes
Timeline
20042005

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00144599 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis

← Back to all trials